CSPG4 and cancer: The transmembrane chondroitin sulfate proteoglycan 4 (CSPG4) has been shown to positively regulate cancer cell proliferation in various cancer entities (Wang et al., 2011; Jamil et al., 2016; Hsu et al., 2018) and is currently under investigation for CTC capture and identification, as described in detail later.